Overview
Hitoshi Sakuraba practices in Kiyose, Japan. Mr. Sakuraba is rated as a Distinguished expert by MediFind in the treatment of Tay-Sachs Disease. His top areas of expertise are Sandhoff Disease, Fabry Disease, Tay-Sachs Disease, Gangliosidosis, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 72 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Tay-Sachs Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fabry DiseaseMr. Sakuraba isDistinguished. Learn about Fabry Disease.
- GangliosidosisMr. Sakuraba isDistinguished. Learn about Gangliosidosis.
- Sandhoff DiseaseMr. Sakuraba isDistinguished. Learn about Sandhoff Disease.
- Tay-Sachs DiseaseMr. Sakuraba isDistinguished. Learn about Tay-Sachs Disease.
- Advanced
- Krabbe DiseaseMr. Sakuraba isAdvanced. Learn about Krabbe Disease.
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3
- Experienced
- Bone Marrow AspirationMr. Sakuraba isExperienced. Learn about Bone Marrow Aspiration.
- CACH SyndromeMr. Sakuraba isExperienced. Learn about CACH Syndrome.
- Mucopolysaccharidoses (MPS)Mr. Sakuraba isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)